Angiotensin-converting enzyme 2 and AMPK/mTOR pathway in the treatment of liver fibrosis: Should we consider further implications?

doi:10.3748/wjg.v30.i18.2391

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 30, Issue 18

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (785)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series.

Item

Count

PDF

HTML

659

Figures (1-1)

Sum=728

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=25

May 14, 2024 (publication date) through Jun 15, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Editorial

World J Gastroenterol. May 14, 2024; 30(18): 2391-2396
Published online May 14, 2024. doi: 10.3748/wjg.v30.i18.2391

Full Size Figure Download Figure

Figure 1 Renin-angiotensin system main pathways. AGT: Angiotensinogen; Ang I: Angiotensin I; ACE: Angiotensin-converting enzyme; ACE2: Angiotensin-converting enzyme 2; ARBs: Angiotensin receptor blokers; AT1R: Angiotensin II type 1 receptor; AT2R: Angiotensin II type 2 receptor; Ang 1-7: Angiotensin 1-7; MasR: G-protein-coupled Mas receptor; MrgD: Mas-related G-protein-coupled receptor D; AMPK: AMP-activated protein kinase; RAS: Renin-angiotensin system.

Citation: Barone M. Angiotensin-converting enzyme 2 and AMPK/mTOR pathway in the treatment of liver fibrosis: Should we consider further implications? World J Gastroenterol 2024; 30(18): 2391-2396
URL: https://www.wjgnet.com/1007-9327/full/v30/i18/2391.htm
DOI: https://dx.doi.org/10.3748/wjg.v30.i18.2391